Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 5, 2026, 11:14 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1–24 of 38 matching trials from the live ClinicalTrials.gov search.

Filters: Condition: Catheter Ablation, Radiofrequency Clear all

Conditions: Ventricular Tachycardia
Interventions: Data Collection Forms; Other
Lead sponsor: Dhanunjaya Lakkireddy, MD, FACC; Other
Eligibility: 18 Years and older
Enrollment: 11 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 1
States / cities: Kansas City, Kansas

Conditions: Atrial Fibrillation
Interventions: EnsoETM, Conventional Care; Device · Procedure
Lead sponsor: Riverside Medical Center; Other
Eligibility: 18 Years to 90 Years
Enrollment: 6 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018
U.S. locations: 1
States / cities: Kankakee, Illinois

Conditions: Atrial Fibrillation, Mitral Valve Insufficiency, Mitral Valve Stenosis
Interventions: MVS, Ablation; Procedure · Device
Lead sponsor: Annetine Gelijns; Other
Eligibility: 18 Years and older
Enrollment: 260 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2015
U.S. locations: 18
States / cities: New Haven, Connecticut • Newark, Delaware • Atlanta, Georgia + 14 more

Conditions: Atrial Fibrillation, Gastrointestinal Tract, Radiofrequency Catheter Ablation
Interventions: Not listed
Lead sponsor: Intermountain Health Care, Inc.; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2015 – 2016
U.S. locations: 1
States / cities: Murray, Utah

Conditions: Atrial Fibrillation
Interventions: Pulmonary Vein Isolation performed by Catheter Ablation, Conventional Antiarrhythmic Drug Therapy; Procedure · Drug
Lead sponsor: Population Health Research Institute; Other
Eligibility: 19 Years to 75 Years
Enrollment: 127 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2006 – 2012
U.S. locations: 2
States / cities: Austin, Texas

Conditions: Arrhythmia
Interventions: Not listed
Lead sponsor: Stiftung Institut fuer Herzinfarktforschung; Other
Eligibility: 18 Years and older
Enrollment: 4,071 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2017
U.S. locations: 1
States / cities: Asheville, North Carolina

Conditions: Atrial Fibrillation
Interventions: Not listed
Lead sponsor: Sumit Verma, MD; Other
Eligibility: 18 Years to 80 Years
Enrollment: 100 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2017 – 2019
U.S. locations: 1
States / cities: Pensacola, Florida

Conditions: Atrial Fibrillation
Interventions: Solumedrol, Placebo; Drug
Lead sponsor: Minneapolis Heart Institute Foundation; Other
Eligibility: 18 Years and older
Enrollment: 119 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2008 – 2013
U.S. locations: 1
States / cities: Minneapolis, Minnesota

Conditions: Atrial Fibrillation (AF), Atrial Arrhythmia, Paroxysmal AF, Drug Refractory Paroxysmal Atrial Fibrillation
Interventions: PFA Ablation catheter; Device
Lead sponsor: Abbott Medical Devices; Industry
Eligibility: 18 Years and older
Enrollment: 188 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 29
States / cities: Scottsdale, Arizona • Little Rock, Arkansas • Stanford, California + 24 more

Conditions: Obstruction of Biliary Tree, Biliary Tract Cancer, Biliary Tract Neoplasms
Interventions: Radiofrequency ablation catheter (Habib EndoHBP); Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years and older
Enrollment: 1 participant
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2014
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Persistent Atrial Fibrillation, Longstanding Persistent Atrial Fibrillation
Interventions: Hybrid: AtriCure Bipolar System & EP ablation procedure; Device
Lead sponsor: AtriCure, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 24 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2013
U.S. locations: 5
States / cities: Stanford, California • Nashville, Tennessee • Plano, Texas + 2 more

Conditions: Heart Diseases, Arrhythmia, Atrial Fibrillation
Interventions: NAVISTAR® THERMOCOOL® Catheter, Antiarrhythmic drug; Device · Drug
Lead sponsor: Biosense Webster, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 167 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2004 – 2011
U.S. locations: 13
States / cities: Greenbrae, California • Orlando, Florida • Maywood, Illinois + 9 more

Conditions: Atrial Flutter
Interventions: Blazer® Open-Irrigated Ablation Catheter, Control Catheter; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 302 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2011 – 2014
U.S. locations: 26
States / cities: Birmingham, Alabama • Fullerton, California • Sacramento, California + 21 more

Conditions: Atrial Fibrillation (AF), Persistent Atrial Fibrillation, Paroxysmal Atrial Fibrillation (PAF)
Interventions: Sphere-9 Catheter Ablation; Device
Lead sponsor: Medtronic Cardiac Ablation Solutions; Industry
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 22
States / cities: Birmingham, Alabama • La Jolla, California • Los Angeles, California + 19 more

Conditions: Catheter Ablation, Radiofrequency
Interventions: VASCADE MVP and MVP XL; Device
Lead sponsor: University of Pennsylvania; Other
Eligibility: 18 Years and older
Enrollment: 150 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2028
U.S. locations: 1
States / cities: Philadelphia, Pennsylvania

Conditions: Paroxysmal Atrial Fibrillation
Interventions: Radiofrequency ablation, antiarrhythmic drugs, Amiodarone, flecainide, propafenone, quinidine, dofetilide, sotalol, cibenzoline, beta blocking and calcium channel blocking agents and antiarrhythmic drugs, ThermoCool Radiofrequency Catheter; Device · Drug
Lead sponsor: Biosense Webster, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2003 – 2006
U.S. locations: 3
States / cities: Birmingham, Alabama • Boston, Massachusetts • Columbus, Ohio

Conditions: Thromboembolism
Interventions: Coumadin; Drug
Lead sponsor: Texas Cardiac Arrhythmia Research Foundation; Other
Eligibility: 18 Years to 75 Years
Enrollment: 1,584 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2014
U.S. locations: 1
States / cities: Austin, Texas

Conditions: Atrial Fibrillation
Interventions: ThermoCool® SF NAV Catheter, ThermoCool® catheter; Device
Lead sponsor: Wake Forest University Health Sciences; Other
Eligibility: 18 Years and older
Enrollment: 13 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2016
U.S. locations: 1
States / cities: Park Ridge, Illinois

Conditions: Paroxysmal Atrial Fibrillation (PAF)
Interventions: Blazer Open-Irrigated Ablation Catheter (Boston Scientific), FDA Approved Open-Irrigated Ablation Catheter; Device
Lead sponsor: Boston Scientific Corporation; Industry
Eligibility: 18 Years and older
Enrollment: 398 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2016
U.S. locations: 27
States / cities: Birmingham, Alabama • Huntsville, Alabama • Redwood City, California + 23 more

Conditions: Atrial Fibrillation
Interventions: DE-MRI; Procedure
Lead sponsor: University of Utah; Other
Eligibility: 18 Years and older
Enrollment: 339 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2010 – 2012
U.S. locations: 5
States / cities: Tampa, Florida • Chicago, Illinois • Columbus, Ohio + 2 more

Conditions: Atrial Fibrillation
Interventions: Ablation procedure staged catheter ablation; Device
Lead sponsor: AtriCure, Inc.; Industry
Eligibility: 18 Years and older
Enrollment: 30 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2012 – 2015
U.S. locations: 4
States / cities: Stanford, California • Colorado Springs, Colorado • Nashville, Tennessee + 1 more

Conditions: Premature Ventricular Contractions, Congestive Heart Failure
Interventions: PVC ablation; Device
Lead sponsor: University of Maryland, Baltimore; Other
Eligibility: 18 Years and older
Enrollment: 3 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 7
States / cities: Los Angeles, California • Baltimore, Maryland • Boston, Massachusetts + 3 more

Conditions: Atrial Fibrillation
Interventions: Multi-Electrode RF Balloon Catheter; Device
Lead sponsor: Biosense Webster, Inc.; Industry
Eligibility: 18 Years to 75 Years
Enrollment: 397 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2022
U.S. locations: 37
States / cities: Phoenix, Arizona • Los Angeles, California • Newport Beach, California + 32 more

Conditions: Atrial Fibrillation
Interventions: Radiofrequency catheter ablation, Amiodarone and cardioversion; Procedure · Drug
Lead sponsor: University of Michigan; Other
Eligibility: 18 Years to 70 Years
Enrollment: 140 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2002 – 2005
U.S. locations: 1
States / cities: Ann Arbor, Michigan

Search by objective public record fields.

Brain Perfusion and Hemodynamic Stability in Patients Undergoing Radiofrequency Ablation of Ventricular Tachycardia

Esophageal Cooling in Radiofrequency Cardiac Ablation

Surgical Ablation Versus No Surgical Ablation for Patients With Atrial Fibrillation Undergoing Mitral Valve Surgery

Vagus Nerve Injury Post Radiofrequency Catheter Ablation for Atrial Fibrillation

First Line Radiofrequency Ablation Versus Antiarrhythmic Drugs for Atrial Fibrillation Treatment (The RAAFT Study)

FREEZE Cohort Study

Assess Differences in Pain Following Cryo and Radiofrequency Atrial Fibrillation Ablation

Corticosteroid Pulse After Ablation

A Study of the TactiFlex SE Catheter and Volt PFA Generator in Subjects With PAF:

Endoscopic Therapy of Malignant Bile Duct Strictures

Dual Epicardial Endocardial Persistent Atrial Fibrillation (AF) Study

NAVISTAR® THERMOCOOL® Catheter for the Radiofrequency Ablation of Symptomatic Paroxysmal Atrial Fibrillation

Clinical Evaluation of the Blazer® Open-Irrigated Catheter for Treatment of Type 1 Atrial Flutter

Conquer-AF Protocol for Redo Ablation Procedures in Recurrent Paroxysmal and Persistent Atrial Fibrillation Using the Sphere-9 Catheter and Affera Ablation System (Conquer-AF)

Early Ambulation Safety Evaluation, Ultrasound-guided Percutaneous Venous Closure

A Comparison of Antiarrhythmic Drug Therapy and Radio Frequency Catheter Ablation in Patients With Paroxysmal Atrial Fibrillation

Role of Coumadin in Preventing Thromboembolism in Atrial Fibrillation (AF) Patients Undergoing Catheter Ablation

Atrial Pressure Electrophysiology Pilot Study

Clinical Evaluation of the Blazer Open-Irrigated Ablation Catheter for the Treatment of Paroxysmal Atrial Fibrillation

DECAAF: Delayed-Enhancement MRI (DE-MRI) Determinant of Successful Radiofrequency Catheter Ablation of Atrial Fibrillation

Dual Epicardial Endocardial Persistent Atrial Fibrillation(AF) Study (Staged DEEP)

Early Elimination of Premature Ventricular Contractions in Heart Failure

Safety and Effectiveness Evaluation of the Multi-Electrode Radiofrequency Balloon Catheter for the Treatment of Symptomatic Paroxysmal Atrial Fibrillation

Radiofrequency Catheter Ablation for Chronic Atrial Fibrillation